ArticleAdvances in therapy2023

Matching-Adjusted Indirect Comparisons of Brexucabtagene Autoleucel with Alternative Standard Therapies for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients.

Bijal Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.